The prevalence of hypogonadism was 38.7% in men aged ≥45 years presenting to primary care offices, with significantly higher rates in men with obesity and/or type 2 diabetes, regardless of age.1,2,3
The Tackle TD campaign has been developed to raise awareness of testosterone deficiency (TD) and aims to provide men who may have the condition with the information and resources they require to seek the help they need.
What is TD?
It’s a hormonal change that AFFECTS MEN OF ANY AGE which results in a very low testosterone level...
Restore the man is organised and funded by Bayer and may contain some promotional content.
Licensed for: In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
This website is intended for Healthcare Professionals resident in the UK.